Physician

Francis Paul Sajben, MD

According to 2025 Medicare claims, Francis Sajben, MD (NPI: 1427119676) practices dermatology in the Chico, CA market, with the plurality of this provider's patient population coming from Butte, CA. This provider's primary affiliated billing organization is REDDING DERMATOLOGY MEDICAL GROUP, INC. (NPI: 1275561151; TIN: 330735011) and primary practice location at 95928-8961.

Sajben's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,255 traditional Medicare patients, billed 7,455 HCPCS/CPT codes, and received $569,863 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,018 prescription claims across 488 beneficiaries totaling $627,439 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 79 records totaling $1,437. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $607,922 and ending at $569,863. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $285,457 to $627,439. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$536K$1.1M2015 Medicare payment: $607,922 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $623,218 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $681,504 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $784,561 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,071,843 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $232,293 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $672,751 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $625,593 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $649,690 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $569,863 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,4208,663$607,922
20161,4058,849$623,218
20171,6358,744$681,504
20181,95712,740$784,561
20192,34117,201$1,071,843
20208894,026$232,293
20211,4337,892$672,751
20221,3077,299$625,593
20231,3947,591$649,690
20241,2557,455$569,863

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$314K$627K2015 Drug cost: $285,457 (USD; Tot_Drug_Cst)2016 Drug cost: $217,947 (USD; Tot_Drug_Cst)2017 Drug cost: $281,444 (USD; Tot_Drug_Cst)2018 Drug cost: $345,556 (USD; Tot_Drug_Cst)2019 Drug cost: $211,205 (USD; Tot_Drug_Cst)2020 Drug cost: $117,496 (USD; Tot_Drug_Cst)2021 Drug cost: $518,903 (USD; Tot_Drug_Cst)2022 Drug cost: $526,583 (USD; Tot_Drug_Cst)2023 Drug cost: $546,785 (USD; Tot_Drug_Cst)2024 Drug cost: $627,439 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015343678$285,457
2016367709$217,947
2017402778$281,444
2018369709$345,556
2019405809$211,205
2020184288$117,496
2021458886$518,903
2022453972$526,583
20235201,037$546,785
20244881,018$627,439

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths316385$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8531,320$62
17000Destruction of precancer skin growth, 1 growth439546$38
88305Pathology examination of tissue using a microscope, intermediate complexity320553$28
17003Destruction of precancer skin growth, 2-14 growths3311,957$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab431,204$163,290
Dupixent SyringeDupilumab19700$90,612
Humira(Cf) PenAdalimumab13364$83,695
ZoryveRoflumilast17562$15,043
TacrolimusTacrolimus461,320$3,085

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.79$1,437Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Francis Paul Sajben, MD?

Tedicare shows public-source Medicare data for Francis Paul Sajben, MD (NPI 1427119676), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Francis Paul Sajben, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Francis Paul Sajben, MD?

Francis Paul Sajben, MD is linked to REDDING DERMATOLOGY MEDICAL GROUP, INC. (billing NPI 1275561151) in the available physician profile data.

Does Francis Paul Sajben, MD have Open Payments data?

Francis Paul Sajben, MD has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.